tyrosine and Stroke
tyrosine has been researched along with Stroke in 72 studies
Research
Studies (72)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 28 (38.89) | 29.6817 |
| 2010's | 38 (52.78) | 24.3611 |
| 2020's | 6 (8.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Huang, W; Lei, B; Li, F; Li, H; Liu, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Yang, Q; Zhang, M; Zhou, P; Zhou, Z; Zi, W | 1 |
| Fei, G; Li, Q; Lin, L; Qi, B; Xu, B; Zhang, Y | 1 |
| Hu, J; Huang, J; Kong, W; Li, F; Li, L; Liu, S; Luo, W; Nogueira, RG; Qiu, Z; Sang, H; Saver, JL; Song, J; Tian, Y; Yang, J; Yang, Q; Zi, W | 1 |
| Altmann, S; Brockmann, C; Brockmann, MA; Dillinger, D; Kerz, T; Maus, V; Mpotsaris, A; Othman, AE; Ringel, F; Spreer, A; Waldeck, S | 1 |
| Afonso, C; Bonino, L; Borthagaray, G; López, E; Medeiros, R; Pitt, A; Rossi, S; Sousa, B; Spickett, C | 1 |
| Akhtari, S; Chandran, V; Colaco, K; Cook, RJ; Eder, L; Gladman, DD; Harvey, P; Lee, KA; McInnes, IB; Piguet, V; Sattar, N; Welsh, P; Winer, R | 1 |
| Ballotta, E; Baracchini, C; Causin, F; Cester, G; Farina, F; Favaretto, S; Kulyk, C; Nico, L; Palmieri, A; Soso, M; Viaro, F | 1 |
| Che, R; Chen, J; Duan, J; Feng, W; Ji, X; Li, C; Liebeskind, D; Ling, F; Shang, S; Song, H; Wang, Y; Wu, C; Wu, L; Zhang, H; Zhao, W | 1 |
| Feng, W; Huang, SH; Li, W; Li, XS; Liang, CR; Lin, L; Liu, CC; Wang, H; Wang, YJ; Wu, Y; Xu, ZQ; Zhang, LL; Zhang, M | 1 |
| Nash, KM; Schiefer, IT; Shah, ZA | 1 |
| Gao, D; Hu, S; Li, H; Li, M; Wang, H; Zhang, H; Zhu, J | 1 |
| Arumugam, TV; Broughton, BR; Chu, HX; Drummond, GR; Evans, MA; Gelderblom, M; Huber, S; Kim, HA; Lee, S; Magnus, T; Piepke, M; Sakkal, S; Shim, R; Sobey, CG; Vinh, A; Wong, CH; Zhang, SR | 1 |
| Bendszus, M; Hacke, W; Hametner, C; Kellert, L; Ringleb, P; Rohde, S; Stampfl, S | 1 |
| Bogdahn, U; Schlachetzki, F; Schuierer, G | 1 |
| Hametner, C; Kellert, L; Stampfl, S | 1 |
| Aass, HC; Amthor, KF; Ormstad, H; Sandvik, L; Verkerk, R | 1 |
| Abraha, I; Ciccone, A; Cozzolino, F; Motto, C; Santilli, I | 1 |
| Baik, SK; Hwang, YH; Kang, DH; Kim, YS; Kim, YW; Park, SP | 1 |
| Chen, JH; Kuo, HC; Lee, KF; Tsai, TH | 1 |
| Du, CP; Hou, XY; Kong, FS; Li, T; Liu, Y; Sun, CC; Wang, Y; Xu, H; Zhu, QJ | 1 |
| Alameda, F; Bosch-Morató, M; Caballo, C; Escolar, G; Galan, AM; Gil-Gómez, G; Guivernau, B; Guix, FX; Ill-Raga, G; Jiménez-Conde, J; Lopez-Vilchez, I; Muñoz, FJ; Ois, A; Opazo, C; Palomer, E; Pérez-Asensio, F; Planas, AM; Ramos-Fernández, E; Reyes-Navarro, M; Roquer, J; Tajes, M; Valls-Comamala, V; Valverde, MA | 1 |
| Abdelsaid, M; Coucha, M; Ergul, A; Fagan, SC; Hafez, S; Johnson, MH; Li, W; Prakash, R | 1 |
| Ganti, L | 1 |
| Bijak, M; Cichoń, N; Miller, E; Niwald, M; Saluk, J | 1 |
| Barry, DM; Dai, XR; Fan, ML; Hou, SX; Jin, H; Kong, F; Lau, LF; Li, TT; Li, XY; Luo, SY; Zhang, GH; Zhou, LL | 1 |
| Chu, IK; Law, HC; Quan, Q; Szeto, SS; Wang, Y; Zhang, Z | 1 |
| Ormstad, H; Sandvik, L; Verkerk, R | 1 |
| Chen, SL; Chen, YD; Chen, YG; Cheng, XS; Ge, JB; Han, YL; Jiang, TM; Li, JL; Li, Y; Liang, ZY; Liu, HW; Liu, ML; Ma, LK; Ma, YT; Wang, G; Wang, HY; Xie, Q; Yang, BS; Zhao, X; Zheng, XQ | 1 |
| Bansilal, S; Becker, RC; Cannon, CP; Harrington, RA; Himmelmann, A; Husted, S; James, SK; Katus, HA; Lopes, RD; Neely, B; Shimada, YJ; Steg, PG; Storey, RF; Wallentin, L; Wiviott, SD | 1 |
| Zhang, W; Zhang, XA | 1 |
| Dempsey, RJ; Kaimal, B; Kim, T; Lyons, K; Mehta, SL; Vemuganti, R | 1 |
| Chen, J; Feng, W; Huang, S; Li, W; Li, X; Liang, C; Lin, L; Liu, C; Wang, Y; Wu, Y; Zhang, M | 1 |
| Glahn, J; Philipps, J; Rother, J; Schwarze, M; Thomalla, G | 1 |
| Boiti, C; Borutti, G; Cazzaniga, M; Falaschi, F; Maestroni, A; Mandelli, C; Manganaro, D; Monzani, V; Rossi, P; Torgano, G; Zecca, B; Zilioli, E | 1 |
| Bosnyak, E; Koller, A; Komoly, S; Marko, L; Nagy, J; Pusch, G; Szapary, L; Toth, P; Wittmann, I | 1 |
| Cao, W; Glushakov, A; Martynyuk, AE; Mecca, AP; Seubert, CN; Shah, HP; Shi, P; Sumners, C | 1 |
| Oberstrass, H; Ringelstein, A; Seitz, RJ; Siebler, M; Wittsack, HJ | 1 |
| Chern, CM; Liao, JF; Liou, KT; Shen, YC; Wang, YH; Yen, JC | 1 |
| Baik, SK; Hwang, JC; Kwon, JH; Shin, SH; Weon, YC | 1 |
| Fiebach, JB; Hamann, G; Hennerici, MG; Junghans, U; Röther, J; Schneider, D; Seitz, RJ; Siebler, M; Villringer, A; von Reutern, GM; Witte, OW | 1 |
| Brait, VH; De Silva, TM; Drummond, GR; Miller, AA; Sobey, CG | 1 |
| Baik, SK; Lee, JH; Oh, SJ; Park, KP | 1 |
| Hamada, J; Hori, O; Kamide, T; Kawano, T; Kitao, Y; Mohri, H; Munesue, S; Okada, A; Schmidt, AM; Takeichi, T; Yamamoto, H; Yamamoto, Y | 1 |
| Chen, X; Ren, C; Wei, D; Zhao, H | 1 |
| Bang, OY; Byun, HS; Jeon, P; Kim, GM; Kim, JW; Kim, KH | 1 |
| Bassand, JP | 1 |
| Ikeda, M; Ito, T; Suzuki, M; Tabuchi, M; Tomita, I; Tomita, T; Umegaki, K | 1 |
| Hamzavi, M; Junghans, U; Ringleb, PA; Schranz, C; Seitz, RJ; Siebler, M | 1 |
| Haerten, K; Krabbe, C; Raiber, M | 1 |
| Dennis, DM; Glushakov, AV; Kagiyama, T; Martynyuk, AE; Ozcan, MS; Phillips, MI; Roose, B; Seubert, CN; Sumners, C | 1 |
| Aquilani, R; Arcidiaco, P; Arrigoni, N; Boschi, F; Dossena, M; Iadarola, P; Pastoris, O; Scocchi, M; Sessarego, P; Verri, M | 1 |
| Albuquerque, FC; Deshmukh, VR; Fiorella, DJ; Flaster, M; Frey, J; McDougall, CG; Spetzler, RF; Wallace, RC | 1 |
| Ikeda, K; Xu, JW; Yamori, Y | 1 |
| Coull, BM; McDonagh, PF; Ritter, LS; Stempel, KM | 1 |
| Dambrink, JH; de Boer, MJ; De Luca, G; Ernst, N; Gosslink, AT; Hoorntje, JC; Ottervanger, JP; Smit, JJ; Suryapranata, H; van 't Hof, AW | 1 |
| Ikami, T; Ikeda, K; Kayano, Y; Kobayakawa, A; Li, PG; Mitani, T; Xu, JW; Yamori, Y | 1 |
| Cellerini, M; Gensini, G; Inzitari, D; Mangiafico, S; Nencini, P | 1 |
| Chaki, S; Craft, TK; DeVries, AC; Khanna, S; Notestine, MA; Parinandi, NL; Rink, C; Roy, S; Sen, CK; Slivka, A | 1 |
| Bukow, SC; Daffertshofer, M; Hennerici, MG | 1 |
| Elango, C; Jatana, M; Khan, M; Paintlia, AS; Singh, AK; Singh, I | 1 |
| Blazing, M; Braunwald, E; Califf, R; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD | 1 |
| Amaro, S; Chamorro, A; Planas, AM; Romanos, E | 1 |
| Del Pace, S; Scheggi, V | 1 |
| Amiri, F; Brassard, P; Iglarz, M; Javeshghani, DM; Pu, Q; Schiffrin, EL; Webb, RL | 1 |
| Kent, TA; Mandava, P; Thiagarajan, P | 1 |
| Ben-Ari, Y; Benjelloun, N; Charriaut-Marlangue, C; Ducrocq, S; Plotkine, M | 1 |
| Montalescot, G | 1 |
| Barone, FC; Christopher, TA; Gao, F; Lopez, BL; Ma, XL; Nelson, AH; Yue, TL | 1 |
| Aulich, A; Freund, HJ; Junghans, U; Seitz, RJ; Siebler, M | 1 |
| Giffard, RG; Han, HS; Karabiyikoglu, M; Qiao, Y; Yenari, MA | 1 |
| Iwao, H; Kawano, H; Kim, S; Zhan, Y | 1 |
| Cucchiara, BL; Hurst, RW; Liebeskind, DS; McGarvey, ML; Pollard, JR; Schwartz, ED | 1 |
Reviews
4 review(s) available for tyrosine and Stroke
| Article | Year |
|---|---|
Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Brain Ischemia; Humans; Immunoglobulin Fab Fragments; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Tyrosine | 2014 |
Tirofiban for the treatment of ischaemic stroke.
Topics: Animals; Brain Ischemia; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine | 2006 |
Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.
Topics: Abciximab; Acute Disease; Animals; Antibodies, Monoclonal; Brain Ischemia; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Tyrosine | 2008 |
Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease.
Topics: Arteriosclerosis; Clopidogrel; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Tirofiban; Tyrosine | 2000 |
Trials
8 trial(s) available for tyrosine and Stroke
| Article | Year |
|---|---|
Endovascular treatment with versus without tirofiban for stroke patients with large vessel occlusion: The multicenter, randomized, placebo-controlled, double-blind RESCUE BT study protocol.
Topics: Arterial Occlusive Diseases; Double-Blind Method; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2022 |
RESCUE BT 2, a multicenter, randomized, double-blind, double-dummy trial of intravenous tirofiban in acute ischemic stroke: Study rationale and design.
Topics: Aspirin; Double-Blind Method; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Prospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2023 |
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
Topics: Abciximab; Acute Coronary Syndrome; Adenosine; Aged; Antibodies, Monoclonal; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Graft Occlusion, Vascular; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Peptides; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Stroke; Thrombosis; Ticagrelor; Ticlopidine; Tirofiban; Tyrosine | 2016 |
Treatment of progressive stroke with tirofiban--experience in 35 patients.
Topics: Aged; Arterial Occlusive Diseases; Disease Progression; Female; Humans; Injections, Intravenous; Male; Microcirculation; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Fibrinolytic Agents; Hospital Mortality; Humans; Intracranial Hemorrhages; Italy; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recovery of Function; Stroke; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2010 |
Failed recovery from thrombolysis is predicted by the initial diffusion weighted imaging lesion.
Topics: Aged; Brain Ischemia; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Recovery of Function; Severity of Illness Index; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Tyrosine | 2011 |
Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Radiography; Stroke; Time Factors; Tirofiban; Tyrosine | 2011 |
Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study.
Topics: Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2001 |
Other Studies
60 other study(ies) available for tyrosine and Stroke
| Article | Year |
|---|---|
Metabolomic Characterization of Acute Ischemic Stroke Facilitates Metabolomic Biomarker Discovery.
Topics: Argininosuccinic Acid; Biomarkers; Glucosamine; Glycerophospholipids; Humans; Ischemic Stroke; Lysine; Metabolomics; Oxygen; Phenylalanine; RNA, Transfer; Stroke; Tryptophan; Tyrosine | 2022 |
Safety Profile and Complication Rates in Emergency Off-label Use of Tirofiban in Interventional Neuroradiology : An Observational Dual Center Study.
Topics: Adult; Aged; Aged, 80 and over; Fibrinolytic Agents; Humans; Ischemic Stroke; Middle Aged; Off-Label Use; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2023 |
Identification and relative quantification of 3-nitrotyrosine residues in fibrinogen nitrated in vitro and fibrinogen from ischemic stroke patient plasma using LC-MS/MS.
Topics: Brain Ischemia; Chromatography, Liquid; Fibrinogen; Hemostatics; Humans; Ischemic Stroke; Nitrates; Stroke; Tandem Mass Spectrometry; Tyrosine | 2021 |
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis.
Topics: Adult; Alanine; Angina Pectoris; Apolipoproteins B; Arthritis, Psoriatic; Cardiovascular Diseases; Cholesterol; Fatty Acids, Unsaturated; Female; Heart Failure; Humans; Ischemic Attack, Transient; Lipoproteins, HDL; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Prospective Studies; Psoriasis; Risk Assessment; Stroke; Tyrosine | 2021 |
Stentriever Thrombectomy Failure: A Challenge in Stroke Management.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Carotid Artery Diseases; Cerebral Angiography; Computed Tomography Angiography; Endovascular Procedures; Female; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Intracranial Hemorrhages; Magnetic Resonance Angiography; Male; Middle Aged; Mortality; Prospective Studies; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Failure; Treatment Outcome; Tyrosine; Ultrasonography, Doppler, Transcranial | 2017 |
Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy.
Topics: Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Endpoint Determination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Registries; Risk Factors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Cerebral Angiography; Cerebral Hemorrhage; Computed Tomography Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Proof of Concept Study; Stroke; Time Factors; Time-to-Treatment; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Development of a reactive oxygen species-sensitive nitric oxide synthase inhibitor for the treatment of ischemic stroke.
Topics: Animals; Antioxidants; Caspase 3; Cell Survival; Cells, Cultured; Disease Models, Animal; Humans; Ischemia; Mice; Mice, Inbred C57BL; Microglia; Neurons; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species; Stroke; Tyrosine | 2018 |
Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon, Coronary; Catheters; Drug Administration Routes; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardium; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2018 |
IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke.
Topics: Animals; Brain Injuries; Brain Ischemia; Cytokines; Disease Models, Animal; Inflammation; Interleukin-10; Interleukin-33; Interleukin-4; Lung; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Stroke; Th1 Cells; Th2 Cells; Treatment Outcome; Tyrosine | 2018 |
Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome.
Topics: Aged; Aged, 80 and over; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Risk; Stroke; Thrombectomy; Tirofiban; Tyrosine | 2013 |
Letter by Schlachetzki et al regarding article, "endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome".
Topics: Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Tyrosine | 2013 |
Response to letter regarding article, "endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome".
Topics: Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thrombectomy; Tyrosine | 2013 |
Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Catecholamines; Cytokines; Female; Glucose; Humans; Inflammation; Male; Middle Aged; Stroke; Tryptophan; Tyrosine | 2013 |
Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2014 |
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine.
Topics: Animals; Biphenyl Compounds; Blotting, Western; Brain; Brain Ischemia; Cell Death; Endoplasmic Reticulum Stress; Immunohistochemistry; Indicators and Reagents; Ischemic Attack, Transient; Lignans; Male; Neurons; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase Type II; Oncogene Protein v-akt; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Stroke; Transcription Factor CHOP; Tyrosine | 2014 |
Tyrosine phosphorylation of GluK2 up-regulates kainate receptor-mediated responses and downstream signaling after brain ischemia.
Topics: Animals; Brain Ischemia; GluK2 Kainate Receptor; HEK293 Cells; Hippocampus; Humans; Male; Mitogen-Activated Protein Kinase 10; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Signal Transduction; src-Family Kinases; Stroke; Tyrosine; Up-Regulation | 2014 |
Fibrinogen nitrotyrosination after ischemic stroke impairs thrombolysis and promotes neuronal death.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Brain; Brain Ischemia; Caspase 3; Cell Line, Tumor; Enzyme Activation; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neurons; Rats; Rats, Sprague-Dawley; Stroke; Tyrosine | 2015 |
Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes.
Topics: Animals; Apoptosis; Brain; Diabetes Mellitus; Metformin; Neovascularization, Physiologic; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein Subunits; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Stress, Physiological; Stroke; Tyrosine | 2015 |
Do Glycoprotein IIb/IIIa Inhibitors Improve Outcomes in Acute Ischemic Stroke?
Topics: Antibodies, Monoclonal; Aspirin; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tyrosine | 2015 |
Poststroke depression as a factor adversely affecting the level of oxidative damage to plasma proteins during a brain stroke.
Topics: Aged; Aged, 80 and over; Blood Proteins; Catalase; Depression; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Humans; Male; Middle Aged; Oxidative Stress; Spectrophotometry; Stroke; Sulfhydryl Compounds; Tyrosine | 2015 |
A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.
Topics: Animals; Bleeding Time; Blood Platelets; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Crotalid Venoms; Dose-Response Relationship, Drug; Fibrin; Infarction, Middle Cerebral Artery; Lectins, C-Type; Male; Mice; Platelet Glycoprotein GPIb-IX Complex; Protective Agents; Reperfusion Injury; Stroke; Tirofiban; Tyrosine; von Willebrand Factor | 2015 |
Fully automated multidimensional reversed-phase liquid chromatography with tandem anion/cation exchange columns for simultaneous global endogenous tyrosine nitration detection, integral membrane protein characterization, and quantitative proteomics mappin
Topics: Animals; Brain; Chromatography, Ion Exchange; Chromatography, Reverse-Phase; Equipment Design; Macaca fascicularis; Male; Membrane Proteins; Nitro Compounds; Proteomics; Stroke; Tyrosine | 2015 |
Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Case-Control Studies; Female; Humans; Male; Middle Aged; Phenylalanine; Stroke; Tyrosine | 2016 |
[A large-scale, multicenter, retrospective study on efficacy of bivalirudin use during peri-percutaneous coronary intervention period for Chinese patients with coronary heart disease].
Topics: Aged; China; Coronary Disease; Female; Hemorrhage; Heparin; Hirudins; Humans; Male; Peptide Fragments; Percutaneous Coronary Intervention; Recombinant Proteins; Retrospective Studies; Stroke; Tirofiban; Tyrosine | 2016 |
A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis.
Topics: Aged; Biomarkers; Caproates; Case-Control Studies; Depression; Dicarboxylic Acids; Female; Glyceric Acids; Humans; Hydroxy Acids; Male; Metabolome; Middle Aged; Phenylalanine; Pseudouridine; Stroke; Tyrosine | 2015 |
Poststroke Induction of α-Synuclein Mediates Ischemic Brain Damage.
Topics: alpha-Synuclein; Animals; Brain Infarction; Brain Ischemia; Caspase 3; Death-Associated Protein Kinases; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Motor Activity; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; RNA, Small Interfering; Stroke; Tyrosine | 2016 |
Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients.
Topics: Aged; Brain; Brain Ischemia; Drug Administration Schedule; Female; Fibrinolytic Agents; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Tomography, X-Ray Computed; Treatment Outcome; Tyrosine | 2016 |
Microalbuminuria, indicated by total versus immunoreactive urinary albumins, in acute ischemic stroke patients.
Topics: Aged; Albuminuria; Biomarkers; Brain Ischemia; Chi-Square Distribution; Chromatography, High Pressure Liquid; Creatinine; Humans; Hungary; Immunoassay; Linear Models; Nephelometry and Turbidimetry; Predictive Value of Tests; Prevalence; Prognosis; Severity of Illness Index; Stroke; Tyrosine | 2011 |
Halogenated aromatic amino acid 3,5-dibromo-D: -tyrosine produces beneficial effects in experimental stroke and seizures.
Topics: Animals; Blood Pressure; Brain; Caspase 3; Disease Models, Animal; Endothelin-1; Epilepsy; Heart Rate; Hydrocarbons, Brominated; Infarction, Middle Cerebral Artery; Male; Motor Activity; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stroke; Tyrosine | 2011 |
Andrographolide inhibits PI3K/AKT-dependent NOX2 and iNOS expression protecting mice against hypoxia/ischemia-induced oxidative brain injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cerebral Infarction; Disease Models, Animal; Diterpenes; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Ischemia, Brain; Male; Mice; Mice, Inbred ICR; Microglia; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type II; Nitrosation; Phosphatidylinositol 3-Kinase; Reactive Oxygen Species; Stroke; Superoxides; Tyrosine; Up-Regulation | 2011 |
Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Recovery of Function; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2011 |
Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke.
Topics: Animals; Cerebral Arteries; Cerebrovascular Circulation; Crosses, Genetic; Ischemia; Leukocyte Common Antigens; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Middle Cerebral Artery; Models, Biological; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Reperfusion Injury; Stroke; Superoxides; Tyrosine | 2011 |
Intra-arterial tirofiban infusion for partial recanalization with stagnant flow in hyperacute cerebral ischemic stroke.
Topics: Acute Disease; Adult; Blood Flow Velocity; Brain Ischemia; Cerebral Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2011 |
RAGE mediates vascular injury and inflammation after global cerebral ischemia.
Topics: Animals; Brain Ischemia; Carotid Artery Injuries; Cell Death; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neuroglia; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Real-Time Polymerase Chain Reaction; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Stroke; Tumor Necrosis Factor-alpha; Tyrosine; Vascular System Injuries | 2012 |
The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke.
Topics: Animals; Extremities; Galectins; Inflammation; Ischemic Preconditioning; Nitric Oxide Synthase Type II; Rats; Receptors, Cell Surface; Stroke; Time Factors; Tyrosine | 2012 |
Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: preliminary experience and short term follow-up results.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Feasibility Studies; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Intracranial Hemorrhages; Male; Middle Aged; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2012 |
[Platelet antiaggregation treatment in the aftermath of GUSTO IV, TARGET, TACTICS, and CURE trials].
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Artery Bypass; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Time Factors; Tirofiban; Tyrosine | 2002 |
Fluctuation of serum NO(x) concentration at stroke onset in a rat spontaneous stroke model (M-SHRSP). Peroxynitrite formation in brain lesions.
Topics: Animals; Brain; Immunohistochemistry; Magnetic Resonance Imaging; Male; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Tyrosine | 2002 |
Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.
Topics: Acute Disease; Aged; Case-Control Studies; Drug Therapy, Combination; Feasibility Studies; Fibrinolytic Agents; Humans; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Retrospective Studies; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine | 2003 |
[Efficacy and safety of treatment of acute ischemic stroke with glycoprotein IIb/IIIa receptor blocker in routine clinical practice].
Topics: Adult; Aged; Anticoagulants; Aspirin; Brain; Brain Ischemia; Carotid Arteries; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Eptifibatide; Female; Heparin; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stroke; Ticlopidine; Tirofiban; Tomography, X-Ray Computed; Tyrosine; Ultrasonography, Doppler | 2004 |
Neuroprotective action of halogenated derivatives of L-phenylalanine.
Topics: Animals; Disease Models, Animal; In Vitro Techniques; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Male; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Stroke; Synaptic Transmission; Tyrosine | 2004 |
Plasma precursors of brain catecholaminergic and serotonergic neurotransmitters in rehabilitation patients with ischemic stroke.
Topics: Aged; Brain Ischemia; Case-Control Studies; Humans; Male; Nutritional Status; Stroke; Stroke Rehabilitation; Tryptophan; Tyrosine | 2004 |
Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy.
Topics: Abciximab; Acute Disease; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Brain Ischemia; Chemotherapy, Adjuvant; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine | 2005 |
Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Anilides; Animals; Aorta, Thoracic; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hypertension; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Signal Transduction; Stroke; Superoxides; Tyrosine; Vasoconstrictor Agents | 2004 |
Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion.
Topics: Analysis of Variance; Animals; Anticoagulants; Biomarkers; Blood Platelets; Brain Ischemia; Disease Models, Animal; Flow Cytometry; Inflammation; Leukocytes; Male; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Polysaccharides; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Tirofiban; Tyrosine | 2005 |
Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.
Topics: Aged; Angiography; Angioplasty, Balloon, Coronary; Female; Fibrinolytic Agents; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Perfusion; Stroke; Time Factors; Tirofiban; Tyrosine | 2005 |
Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antioxidants; Caffeic Acids; Cell Division; DNA-Binding Proteins; Drug Interactions; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Hypertension; Janus Kinase 2; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; STAT1 Transcription Factor; Stroke; Superoxides; Trans-Activators; Tyrosine; Tyrphostins; Vasoconstrictor Agents | 2005 |
Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases.
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Catheterization; Combined Modality Therapy; Female; Heparin; Humans; Infarction, Middle Cerebral Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Intracranial Hemorrhages; Male; Middle Aged; Risk; Severity of Illness Index; Stroke; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator | 2005 |
Neuroprotective properties of the natural vitamin E alpha-tocotrienol.
Topics: Animals; Antioxidants; Arachidonate 12-Lipoxygenase; Brain; Cell Death; Cell Line; Cell Survival; Cells, Cultured; Cerebral Cortex; CSK Tyrosine-Protein Kinase; Fluoresceins; Glutamic Acid; Hippocampus; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; Organic Chemicals; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Random Allocation; Rats; Rats, Inbred SHR; src-Family Kinases; Stroke; Time Factors; Tocotrienols; Transfection; Tyrosine; Vitamin E | 2005 |
Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke.
Topics: Animals; Brain Chemistry; Brain Ischemia; Glutathione; Glutathione Disulfide; Lipid Peroxidation; Lipids; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Stroke; Structure-Activity Relationship; Tyrosine | 2006 |
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Case Management; Chemical and Drug Induced Liver Injury; Comorbidity; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Endpoint Determination; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Tables; Lipids; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Simvastatin; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2006 |
Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
Topics: Animals; Brain Damage, Chronic; Brain Edema; Humans; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Neutrophil Infiltration; Nitrates; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Stroke; Thromboembolism; Tissue Plasminogen Activator; Tyrosine; Uric Acid | 2007 |
Acute ischaemic stroke treated with combined intra-arterial thrombolysis and intravenous tirofiban despite oral anticoagulant therapy at an international normalised ratio > or = 2.0.
Topics: Acute Disease; Administration, Oral; Aged; Anticoagulants; Brain Ischemia; Contraindications; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Patient Selection; Stroke; Thrombolytic Therapy; Tirofiban; Tyrosine | 2006 |
Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Endomyocardial Fibrosis; Endothelium, Vascular; Hydralazine; Hypertension; Male; Mesenteric Arteries; Neprilysin; Rats; Rats, Inbred SHR; Rats, Wistar; Stroke; Tetrazoles; Tyrosine; Valine; Valsartan | 2008 |
Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain.
Topics: Animals; Animals, Newborn; Benzamides; Brain Ischemia; Cell Death; Cerebral Infarction; Encephalitis; Female; Male; Motor Activity; Neurologic Examination; Neuroprotective Agents; Neutrophils; Nitrates; Poly(ADP-ribose) Polymerase Inhibitors; Polymers; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Stroke; Time Factors; Tyrosine | 2000 |
Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Apoptosis; Blood Pressure; Carbazoles; Carvedilol; Endothelium, Vascular; Immunohistochemistry; In Situ Nick-End Labeling; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidation-Reduction; Propanolamines; Rats; Rats, Inbred SHR; Stroke; Tyrosine | 2001 |
Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Encephalitis; Hypothermia, Induced; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Male; Microglia; Monocytes; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Stroke; Tyrosine | 2002 |
Enhancement of glomerular platelet-derived growth factor beta-receptor tyrosine phosphorylation in hypertensive rats and its inhibition by calcium channel blocker.
Topics: Albuminuria; Animals; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Genetic Predisposition to Disease; Hypertension; Kidney Glomerulus; Male; Phosphorylation; Proteinuria; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Platelet-Derived Growth Factor beta; Stroke; Tyrosine | 2002 |
Vertebrobasilar thrombolysis with intravenous tirofiban: case report.
Topics: Aged; Arterial Occlusive Diseases; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine; Vertebrobasilar Insufficiency | 2002 |